Impact of obesity on immune-related adverse events and tyrosine kinase inhibitor side effects in patients with metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Alharbi, Malak
Tariq, Muhammad Junaid
Jatwani, Karan
George, Saby
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY USA
[2] Roswell Pk Canc Inst, Buffalo, IL USA
[3] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4560
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
    Abou Alaiwi, Sarah
    Xie, Wanling
    Nassar, Amin H.
    Dudani, Shaan
    Martini, Dylan
    Bakouny, Ziad
    Steinharter, John A.
    Nuzzo, Pier Vitale
    Flippot, Ronan
    Martinez-Chanza, Nieves
    Wei, Xiao
    McGregor, Bradley A.
    Kaymakcalan, Marina D.
    Heng, Daniel Y. C.
    Bilen, Mehmet A.
    Choueiri, Toni K.
    Harshman, Lauren C.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [32] A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma
    Wang, Bengang
    Hao, Xiangjun
    Yan, Jinshan
    Li, Xin
    Zhao, Mingfang
    Han, Tao
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2024, 12 (03) : 225 - 243
  • [33] Impact of sex on immune-related adverse events in patients with melanoma
    Ottaviano, Margaret
    Mallardo, Domenico
    Vitale, Maria Grazia
    Vanella, Vito
    Fordellone, Mario
    Festino, Lucia
    Trojaniello, Claudia
    Sparano, Francesca
    Facchini, Bianca Arianna
    Cioli, Eleonora
    Isaja, Antonio
    Cavalcanti, Ernesta
    Capone, Mariaelena
    Madonna, Gabriele
    Paone, Miriam
    Chiodini, Paolo
    Caraco, Corrado
    Simeone, Ester
    Ascierto, Paolo Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] T-Cell Receptor Repertoire as a Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma
    Kobayashi, Takuro
    Nagata, Masayoshi
    Ikehata, Yoshihiro
    Nagashima, Yuki
    Nagaya, Naoya
    Lu, Yan
    Horie, Shigeo
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (11) : 8939 - 8949
  • [35] Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Chehade, Razane El Hajj
    Semaan, Karl
    Saliby, Renee Maria
    Saad, Eddy
    Nawfal, Rashad
    Machaalani, Marc
    Eid, Marc
    Yekeduz, Emre
    Steiner, Clara
    Sun, Maxine
    Kaymakcalan, Marina
    Choueiri, Toni K.
    ONCOLOGIST, 2024, 29
  • [36] The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study
    Taigo Kato
    Akira Nagahara
    Norihiko Kawamura
    Wataru Nakata
    Tetsuji Soda
    Kyosuke Matsuzaki
    Koji Hatano
    Atsunari Kawashima
    Takeshi Ujike
    Ryoichi Imamura
    Kensaku Nishimura
    Shingo Takada
    Masao Tsujihata
    Seiji Yamaguchi
    Tetsuya Takao
    Kazuo Nishimura
    Norio Nonomura
    Motohide Uemura
    International Journal of Clinical Oncology, 2021, 26 : 954 - 961
  • [37] Tyrosine-kinase inhibitor sorafenib (S) in treatment of metastatic renal cell carcinoma cancer (mRCC) with lung metastases
    Popova, Irina L.
    Vladimirova, Liubov Yu
    Abramova, Natalya A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH BETTER SURVIVAL OUTCOMES FOR METASTATIC RENAL CELL CARCINOMA TREATED WITH NIVOLUMAB PLUS IPILIMUMAB
    Numakura, Kazuyuki
    Hatakeyama, Shingo
    Sekine, Yuya
    Muto, Yumina
    Kobayashi, Mizuki
    Kashima, Soki
    Yamamoto, Ryohei
    Koizumi, Atsushi
    Nara, Taketoshi
    Saito, Mitsuru
    Narita, Shintaro
    Ohyama, Chikara
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2022, 207 (05): : E175 - E175
  • [39] The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study
    Kato, Taigo
    Nagahara, Akira
    Kawamura, Norihiko
    Nakata, Wataru
    Soda, Tetsuji
    Matsuzaki, Kyosuke
    Hatano, Koji
    Kawashima, Atsunari
    Ujike, Takeshi
    Imamura, Ryoichi
    Nishimura, Kensaku
    Takada, Shingo
    Tsujihata, Masao
    Yamaguchi, Seiji
    Takao, Tetsuya
    Nishimura, Kazuo
    Nonomura, Norio
    Uemura, Motohide
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (05) : 954 - 961
  • [40] Immune-related adverse events can predict progression-free and overall survival in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Silberg, Matteo
    Krabbe, Laura-Maria
    Boegemann, Martin
    Schrader, Andres Jan
    Schlack, Katrin
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 103 - 103
12345